Knowledge Hub

In-depth research on Firalis SAS - Product Pipeline Analysis, 2016 Update

Press Release   •   Feb 02, 2017 04:57 EST

Firalis SAS (Firalis) is a biotechnology company that discovers and develops biomarkers and biomarker-based diagnostic kits. The companys biomarker products include Elisa kits, recombinant proteins and calibrants, and monoclonal antibodies. It offers biomarker services such as proteomics, genomics and transcriptomics, flow cytometry, metabolomics and lipidomics, assay development, biobanking, biomarker data analysis and biomarker regulatory consultancy services. The company carries out research and development on cardiovascular biomarkers, drug safety and efficacy, patient stratification, personalized medicine and new biomarker technologies. It develops biomarkers related to inflammatory disorders. Firalis is headquartered in Huningue, France.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage

View Report @


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Firalis SAS

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Get Sample Copy Of This Report @

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Firalis SAS Company Overview 6

Firalis SAS Company Snapshot 6

Firalis SAS Pipeline Products and Clinical Trials Overview 6

Firalis SAS Pipeline Analysis Overview 9

Key Facts 9

Firalis SAS - Major Products and Services 10

Firalis SAS Pipeline Products by Development Stage 11

Firalis SAS Pipeline Products Overview 13

Biomarker Test - Rheumatoid Arthritis 13

Biomarker Test - Rheumatoid Arthritis Product Overview 13

Diagnostic Assay - Cardiovascular Diseases 14

Diagnostic Assay - Cardiovascular Diseases Product Overview 14

Diagnostic Kit - Acute Myocardial Infarction 15

Diagnostic Kit - Acute Myocardial Infarction Product Overview 15

Diagnostic Kit - Coxibs and NSAIDs 16

Diagnostic Kit - Coxibs and NSAIDs Product Overview 16

Diagnostic Kit - Drug Induced Vasculitis 17

Diagnostic Kit - Drug Induced Vasculitis Product Overview 17

Diagnostic Kit - Non Drug Induced Vasculitis 18

Diagnostic Kit - Non Drug Induced Vasculitis Product Overview 18

Diagnostic Panel - Vasculitis 19

Diagnostic Panel - Vasculitis Product Overview 19

Micro-ELISA System 20

Micro-ELISA System Product Overview 20

Peripheral Biomarker - Minimal Vasculitis 21

Peripheral Biomarker - Minimal Vasculitis Product Overview 21

Prognostic miRNA Assay - Heart Failure 22

Prognostic miRNA Assay - Heart Failure Product Overview 22

Firalis SAS - Key Competitors 23

Firalis SAS - Key Employees 24

Firalis SAS - Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

Firalis SAS, Recent Developments 26

Sep 19, 2014: Firalis Inaugurated its Biomarker Production Site 26

Feb 24, 2014: Firalis gets certified according to ISO 13485 and ISO 9001 standards; for the development and production of Firalis ELISA kits 26 is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.